U.S. Markets closed

Immune Design lays off workers and shifts course after halting lead cancer vaccine trial

Casey Coombs
American City Business Journals
Immune Design lays off workers and shifts course after halting lead cancer vaccine trial

The layoffs amount to about 20 percent of Immune Design's workforce in Seattle and San Francisco.